Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 2
1(50.0%)
2Total
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05761613Not ApplicableActive Not Recruiting

Ceragenin Coated Endotracheal Tubes for the Prevention of Ventilator Associated Pneumonia

Role: lead

NCT04588792Phase 2Terminated

Furosemide as Supportive Therapy for COVID-19 Respiratory Failure

Role: lead

NCT05509036Completed

Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST) Study Multi-Center Study

Role: lead

NCT04605029Completed

Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients

Role: lead

All 4 trials loaded